Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders
Abstract Translational research made with Cannabis sativa L. and its biocompounds provides data for some targeted diseases, as also symptoms…
Abstract Translational research made with Cannabis sativa L. and its biocompounds provides data for some targeted diseases, as also symptoms…
Abstract Antiseizure medications are the cornerstone pharmacotherapy for epilepsy. They are not devoid of side effects. In search for better-tolerated…
Abstract Introduction: Several drugs of abuse (DOA) are capable of modulating neurohypophysial hormones, such as oxytocin (OT) and vasopressin (VP),…
Abstract Schizophrenia typically emerges during adolescence, with progression from an ultra-high risk state (UHR) to the first episode of psychosis…
Abstract Autism spectrum disorder (ASD) pathophysiology is not completely understood; however, altered inflammatory response and glutamate signaling have been reported,…
Abstract Treatment-resistance is a frequent condition for obsessive-compulsive disorder (OCD). Over the past decades, a lot of effort has been…
Abstract Rationale: Initial exposure to cannabinoids, including Δ-9-tetrahydrocannabinol (THC), often occurs during adolescence. Considerable neurodevelopmental alterations occur throughout adolescence, and…
Abstract In the central nervous system, glutamate is a major excitable neurotransmitter responsible for many cellular functions. However, excessive levels…
Abstract Glia form a central component of the nervous system whose varied activities sustain an environment that is optimised for…
Abstract The basic mechanism of the major neurodegenerative diseases, including neurogenic pain, needs to be agreed upon before rational treatments…